Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Suicide risk with selective serotonin reuptake inhibitors and new-generation serotonergic-noradrenergic antidepressants in adults: a systematic review and meta-analysis of observational studies

View ORCID ProfileMichael P Hengartner, Simone Amendola, Jakob A Kaminski, Simone Kindler, Tom Bschor, Martin Plöderl
doi: https://doi.org/10.1101/2020.05.11.20098178
Michael P Hengartner
1Department of Applied Psychology, Zurich University of Applied Sciences, CH-8037 Zurich, Switzerland,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael P Hengartner
  • For correspondence: heng{at}zhaw.ch
Simone Amendola
2Department of Dynamic and Clinical Psychology, Faculty of Medicine and Psychology, Sapienza University of Rome, 00185 Roma RM, Italy,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jakob A Kaminski
3Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simone Kindler
4Psychotherapist in private practice, CH-8400 Winterthur, Switzerland,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom Bschor
5Department of Psychiatry and Psychotherapy, University Hospital, Technical University of Dresden, 01069 Dresden, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Plöderl
6Department of Crisis Intervention and Suicide Prevention, Christian Doppler Clinic, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Data Availability

Data and statistical code will be made freely available upon publication of the study in a scientific journal

https://osf.io/eaqwn/

Back to top
PreviousNext
Posted May 19, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Suicide risk with selective serotonin reuptake inhibitors and new-generation serotonergic-noradrenergic antidepressants in adults: a systematic review and meta-analysis of observational studies
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Suicide risk with selective serotonin reuptake inhibitors and new-generation serotonergic-noradrenergic antidepressants in adults: a systematic review and meta-analysis of observational studies
Michael P Hengartner, Simone Amendola, Jakob A Kaminski, Simone Kindler, Tom Bschor, Martin Plöderl
medRxiv 2020.05.11.20098178; doi: https://doi.org/10.1101/2020.05.11.20098178
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Suicide risk with selective serotonin reuptake inhibitors and new-generation serotonergic-noradrenergic antidepressants in adults: a systematic review and meta-analysis of observational studies
Michael P Hengartner, Simone Amendola, Jakob A Kaminski, Simone Kindler, Tom Bschor, Martin Plöderl
medRxiv 2020.05.11.20098178; doi: https://doi.org/10.1101/2020.05.11.20098178

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)